C-reactive protein (CRP) after revascularized STEMI: Is CRP a prognostic factor?;Intérêt de la C-reactive protein (CRP) dans l'évaluation pronostique de l'infarctus du myocarde revascularisé

Revue de Medecine Interne

Volumn 29, Issue 11, 2008, Pages 868-874

  Roubille, F ^a   Cayla, G ^a   Picot, M C ^a   Pradet, V ^a   Massin, F ^a   Gervasoni, R ^a   Pasquie, J L ^a   Macia, J C ^a   Piot, C ^a   Leclercq, F ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Biomarker; BNP; CRP; CRPus; Pronostic factor; STEMI

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TIME FACTORS; TROPONIN;

EID: 54049150474     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.01.026     Document Type: Article

References (30)

1. Paffen E., and DeMaat M.P. C-reactive protein in atherosclerosis: A causal factor?. Cardiovasc Res 71 1 (2006) 30-39
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 16 (2005) 1685-1695
3. Ridker P.M. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 148 Suppl. 1 (2004) S19-S26
4. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 12 (2000) 836-843
5. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 1 (2005) 20-28
6. Sabatine M.S., Morrow D.A., Jablonski K.A., Rice M.M., Warnica J.W., Domanski M.J., et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 12 (2007) 1528-1536
7. Correia L.C., Lima J.C., Rocha M.S., D'Oliveira Junior A., and Pericles Esteves J. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?. Clin Chim Acta 375 1-2 (2007) 124-128
8. Kavsak P.A., MacRae A.R., Newman A.M., Lustig V., Palomaki G.E., Ko D.T., et al. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem 40 5-6 (2007) 326-329
9. James S.K., Armstrong P., Barnathan E., Califf R., Lindahl B., Siegbahn A., et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 41 6 (2003) 916-924
10. Koenig W., Lowel H., Baumert J., and Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109 11 (2004) 1349-1353
11. Biasucci L.M. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110 25 (2004) e560-e567
12. Nijmeijer R., Lagrand W.K., Lubbers Y.T., Visser C.A., Meijer C.J., Niessen H.W., et al. C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 163 1 (2003) 269-275
13. Berton G., Cordiano R., Palmieri R., Pianca S., Pagliara V., and Palatini P. C-reactive protein in acute myocardial infarction: association with heart failure. Am Heart J 145 6 (2003) 1094-1101
14. Suleiman M., Khatib R., Agmon Y., Mahamid R., Boulos M., Kapeliovich M., et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 47 5 (2006) 962-968
15. Ohlmann P., Jaquemin L., Morel O., El Behlgiti R., Faure A., Michotey M.O., et al. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction. Am Heart J 152 6 (2006) 1161-1167
16. Nikfardjam M., Müllner M., Schreiber W., Oschatz E., Exner M., Domanovits H., et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 247 3 (2000) 341-345
17. Kinjo K., Sato H., Ohnishi Y., Hishida E., Nakatani D., Mizuno H., et al. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 91 8 (2003) 931-935
18. Yip H.K., Hang C.L., Fang C.Y., Hsieh Y.K., Yang C.H., Hung W.C., et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 127 3 (2005) 803-808
19. Hanania G., Cambou J.P., Guéret P., Vaur L., Blanchard D., Lablanche J.M., et al. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry. Heart 90 12 (2004) 1404-1410
20. Danchin N., Kadri Z., Cambou J.P., Hanania G., Humbert R., and Clerson P. Prise en charge de l'infarctus du myocarde en France dans les études USIK 1995 et USIC 2000 : amélioration pronostique et rôle du délai d'admission. Arch Mal Coeur Vaiss 98 11 (2005) 1149-1154
21. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 8 (2004) 1533-1542
22. Selvanayagam J.B., Porto I., Channon K., Petersen S.E., Francis J.M., and Neubauer S. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 111 8 (2005) 1027-1032
23. Kanna M., Nonogi H., Sumida H., Miyazaki S., Daikoku S., Morii I., et al. Usefulness of serum troponin T levels on day three or four in predicting survival after acute myocardial infarction. Am J Cardiol 87 3 (2001) 294-297
24. Panteghini M., Bonetti G., Pagani F., Stefini F., Giubbini R., and Cuccia C. Measurement of troponin I 48 h after admission as a tool to rule out impaired left ventricular function in patients with a first myocardial infarction. Clin Chem Lab Med 43 8 (2005) 848-854
25. Zacharoulis A., Kotseroglou V., Lerakis S., Karavidas A., Arapi S., and Zacharoulis A. Predictive value of C-reactive protein and left ventricular diastolic filling pattern after a non-ST elevation myocardial infarction. Am J Med Sci 331 3 (2006) 113-118
26. Dimitrijevic O., Stojcevski B.D., Ignjatovic S., and Singh N.M. Serial measurements of C-reactive protein after acute myocardial infarction in predicting 1-year outcome. Int Heart J 47 6 (2006) 833-842
27. Tanaka A., Shimada K., Sano T., Namba M., Sakamoto T., Nishida Y., et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 45 10 (2005) 1594-1599
28. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 7088 (2006) 1217-1221
29. Doggrell S.A. Relating statin therapy to C-reactive protein levels. Expert Opin Pharmacother 6 9 (2005) 1597-1600
30. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352 1 (2005) 29-38